Bondex(603836)
Search documents
海程邦达供应链管理股份有限公司董事减持股份计划公告
Shang Hai Zheng Quan Bao· 2025-11-13 18:29
Core Viewpoint - The announcement details a share reduction plan by a director of Haicheng Bangda Supply Chain Management Co., Ltd. due to personal financial needs, involving a potential sale of up to 1,984,000 shares, which represents 0.97% of the company's total shares [3][9]. Group 1: Shareholding Information - As of the announcement date, Director Wang Xiping directly holds 7,936,100 shares, accounting for 3.87% of the company's total shares [2]. - Wang Xiping also indirectly holds an additional 10,597,109 shares through Ningbo Fanruida Venture Capital Partnership, bringing his total shareholding to 9.03% [4]. Group 2: Reduction Plan Details - The reduction plan allows for the sale of shares within three months starting from 15 trading days after the announcement, excluding any periods when trading is suspended [3][6]. - The shares will be sold at market price through centralized bidding or block trading [3]. Group 3: Compliance and Commitments - The director has made prior commitments regarding shareholding, including a lock-up period of 12 months post-IPO and restrictions on the percentage of shares that can be sold annually [7][8]. - The planned reduction aligns with previously disclosed commitments and complies with relevant laws and regulations [9].
中芯国际:前三季净利同比增长41.1%;康达新材:终止筹划收购北一半导体股权丨公告精选
2 1 Shi Ji Jing Ji Bao Dao· 2025-11-13 14:22
Group 1: Company Performance - SMIC reported a revenue of 17.162 billion yuan in Q3 2025, a year-on-year increase of 9.9%, with a net profit of 1.51 billion yuan, up 43.1% year-on-year. For the first three quarters, revenue reached 49.51 billion yuan, growing 18.2%, and net profit was 3.81 billion yuan, an increase of 41.1% year-on-year [1] - BoRui Pharma's BGM1812 injection has received clinical trial approval for weight loss indications, with no similar targeted formulations approved globally [2] - Li Zhong Group's subsidiaries received project confirmations for aluminum alloy wheels from major international automotive manufacturers, with expected total sales of approximately 1.135 billion yuan [4] Group 2: Corporate Actions - Kanda New Materials announced the termination of the acquisition of equity in North One Semiconductor due to unmet progress expectations and lack of consensus among parties [3] - Lide Man plans to acquire 70% of Xiansheng Xiangrui for 1.733 billion yuan, aiming to enter the bioproducts industry [9] - Arctech's controlling shareholder CSIQ expects total revenue of 1.3 to 1.5 billion USD in Q4 2025, with a gross margin of 14% to 16% [6] Group 3: Market Activity - Taihe Technology's VC project phase two construction will be adjusted based on phase one market expansion, indicating some uncertainty [5] - Hezhong China has experienced significant stock price fluctuations, with a cumulative increase of 230.84% over 12 out of 13 trading days, leading to potential application for trading suspension if abnormal price increases continue [7][8]
海程邦达:董事减持股份计划公告
Zheng Quan Ri Bao· 2025-11-13 14:09
Core Points - The company Haicheng Bangda announced that director Wang Xiping holds 7,936,100 shares, representing 3.87% of the total shares [2] - Wang plans to reduce his holdings by up to 1,984,000 shares, which is 0.97% of the total shares, within three months after a 15 trading day period following the announcement [2] - The reduction will be executed through centralized bidding or block trading at market prices [2]
11月13日这些公告有看头
Di Yi Cai Jing Zi Xun· 2025-11-13 13:47
Major Events - Guotai Group acquired 100% equity of Beikuan Baomao for 110 million yuan through public bidding [3] - People's Tongtai stock price has a risk of rapid decline after a 46.43% increase over four consecutive trading days [4] - Huasheng Lithium's revenue increased by 62% in the first three quarters, but the company still reported a loss of 102.97 million yuan [5] - Haizike received approval for clinical trials of the innovative drug HSK39297 for age-related macular degeneration [6] - Angli Education postponed its response to an asset acquisition inquiry for no more than five trading days [7] - Shuguang Co. terminated its plan to issue shares to specific targets, and the Shanghai Stock Exchange has decided to terminate the review [8] Performance Overview - JD Group reported third-quarter revenue of 299.1 billion yuan, a year-on-year increase of 14.9% [9] - SMIC's third-quarter net profit was 1.517 billion yuan, up 43.1% year-on-year [10] - Tencent Holdings achieved third-quarter revenue of 192.87 billion yuan, a 15% year-on-year growth [11] - Lu'an Huaneng's coal sales in October reached 3.78 million tons, a year-on-year increase of 3.28% [12] Shareholding Changes - Haicheng Bangda's director plans to reduce holdings by no more than 0.97% due to personal financial needs [13] - Qisheng Technology's major shareholder reduced their stake to 40% after a transaction [14] - Tianwei Electronics' major shareholder reduced their stake to below 5% [15] - Zhongzi Technology's major shareholders collectively reduced their stake by 1.35% [16] Major Contracts - Lizhong Group's subsidiary received project confirmations with an estimated total sales of approximately 1.135 billion yuan [18] - Anhui Construction's subsidiary won a project bid worth 1.753 billion yuan [19]
晚间公告|11月13日这些公告有看头
Di Yi Cai Jing· 2025-11-13 10:24
Major Announcements - Guotai Group acquired 100% equity of Beikuan Baomao for 110 million yuan through public bidding [3] - People's Tongtai stock price has risen for four consecutive trading days, with a total increase of 46.43%, indicating potential rapid decline risk due to market sentiment [4] - Huasheng Lithium's stock price has deviated significantly, with a 62% revenue increase in the first three quarters, but still reporting a net loss of 10.3 million yuan [5] - Haishi Ke received approval for clinical trials of innovative drug HSK39297 for age-related macular degeneration, showing high development potential [6] - Angli Education postponed its response to an asset acquisition inquiry for no more than five trading days [7] - Shuguang Co. terminated its plan to issue shares to specific targets, with the Shanghai Stock Exchange halting the review [8] Performance Overview - JD Group reported third-quarter revenue of 299.1 billion yuan, a year-on-year increase of 14.9%, with net profit of 5.3 billion yuan [10] - SMIC achieved third-quarter net profit of 1.517 billion yuan, a 43.1% year-on-year increase, with revenue of 17.162 billion yuan [11][12] - Tencent Holdings reported third-quarter revenue of 192.87 billion yuan, a 15% year-on-year increase, with operating profit of 72.57 billion yuan [13] - Lu'an Huaneng's coal sales in October reached 3.78 million tons, a year-on-year increase of 3.28% [14] Shareholding Changes - Haicheng Bangda's director Wang Xiping plans to reduce his holdings by up to 0.97% due to personal financial needs [16] - Qisheng Technology's major shareholder reduced their stake to 40% through a block trade [17] - Tianwei Electronics' major shareholder Xie Kai reduced his holdings to below 5% [18] - Zhongzi Technology's major shareholders collectively reduced their stake by 1.35% [19] Major Contracts - Lichong Group's subsidiaries received project confirmations with an estimated total sales of approximately 1.135 billion yuan [21] - Anhui Construction's subsidiary won a project bid worth 1.753 billion yuan [22]
11月13日晚间重要公告一览
Xi Niu Cai Jing· 2025-11-13 10:11
Group 1 - China Pacific Insurance's subsidiary, China Pacific Life, reported a cumulative premium income of 241.32 billion yuan for the first ten months, a year-on-year increase of 9.9% [1] - China Pacific Property Insurance, another subsidiary, achieved a cumulative premium income of 173.57 billion yuan, with a year-on-year growth of 0.4% [1] - Nocera Biopharma reported a net loss of 64.41 million yuan for the first three quarters, despite a revenue increase of 59.85% to 1.115 billion yuan [1] Group 2 - Founder Securities received approval from the China Securities Regulatory Commission to issue short-term corporate bonds not exceeding 5 billion yuan [1] - Haicheng Bonda's director plans to reduce his stake by up to 0.97%, equating to 198,400 shares [1] - Yuyuan Group intends to repurchase shares worth between 200 million and 300 million yuan, with a maximum price of 8.60 yuan per share [1] Group 3 - Huaren Shuanghe's subsidiary passed the GMP compliance inspection for a specific diabetes medication [4] - Lichong Group received project notifications from three international automotive manufacturers, with expected sales amounting to approximately 1.135 billion yuan [6] - Deyang Co. is planning to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy [7] Group 4 - Longxin General announced the transfer of its entire stake in a subsidiary for 105.6 million yuan, and also plans to divest another stake for 1 yuan due to poor performance [16] - Kangda New Materials decided to terminate the acquisition of a semiconductor company due to unsatisfactory due diligence progress [17] - Lu'an Environmental reported a 3.28% year-on-year increase in coal sales for October, totaling 3.78 million tons [18] Group 5 - Shanghai Port Group plans to invest 2 billion yuan to establish a new holding company with several state-owned enterprises [20] - Borui Pharmaceutical's new drug for obesity treatment has received clinical trial approval [23] - Silver Dragon Co. has completed the registration of a new energy industry fund focusing on high-growth potential projects [24] Group 6 - Hengrui Medicine received approval for a clinical trial of a prostate cancer drug [11] - Baiji Shenzhou reported a net profit of 1.139 billion yuan for the first three quarters, marking a turnaround from losses [36] - Huasheng Pharmaceutical's special medical food product has received registration certification [60]
海程邦达(603836) - 董事减持股份计划公告
2025-11-13 09:33
证券代码:603836 证券简称:海程邦达 公告编号:2025-078 海程邦达供应链管理股份有限公司 董事减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 董事持股的基本情况 截至本公告披露日,海程邦达供应链管理股份有限公司(以下简称"公 司")董事王希平先生直接持有公司股份 7,936,100 股,占公司股份总数的 3.87%。 减持计划的主要内容 因个人资金需求,王希平先生计划自本公告披露之日起 15 个交易日后的 3 个月内(根据中国证监会及上海证券交易所相关规定禁止减持的期间除外),通 过集中竞价交易或大宗交易方式减持公司股份,减持数量不超过 1,984,000 股,占 公司股份总数的 0.97%,减持价格按市场价格确定。 | 股东名称 | 王希平 | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 计划减持数量 | 不超过:1,984,000 股 | | | | | | | 计划减持比例 | 不超过:0.97% ...
海程邦达(603836.SH)董事王希平拟减持不超0.97%股份
智通财经网· 2025-11-13 09:23
Core Points - The company Haicheng Bangda (603836.SH) announced that director Wang Xiping plans to reduce his shareholding due to personal funding needs [1] - The reduction will occur within three months starting from 15 trading days after the announcement date, excluding the period prohibited by the China Securities Regulatory Commission and the Shanghai Stock Exchange [1] - The maximum number of shares Wang Xiping intends to sell is 1.984 million shares, which represents 0.97% of the company's total shares [1] - The selling price will be determined based on market conditions [1]
海程邦达董事王希平拟减持不超0.97%股份
Zhi Tong Cai Jing· 2025-11-13 09:22
Core Viewpoint - The company Haicheng Bangda (603836.SH) announced that director Wang Xiping plans to reduce his shareholding due to personal financial needs, with a maximum reduction of 1.984 million shares, representing 0.97% of the total shares [1] Group 1 - The reduction will occur within three months starting from 15 trading days after the announcement, excluding periods prohibited by the China Securities Regulatory Commission and the Shanghai Stock Exchange [1] - The shares will be sold through centralized bidding or block trading, with the selling price determined by market conditions [1]
海程邦达(603836.SH):董事王希平拟减持不超198.4万股股份
Ge Long Hui A P P· 2025-11-13 09:20
格隆汇11月13日丨海程邦达(603836.SH)公布,因个人资金需求,董事王希平先生计划自本公告披露之 日起15个交易日后的3个月内(根据中国证监会及上海证券交易所相关规定禁止减持的期间除外),通 过集中竞价交易或大宗交易方式减持公司股份,减持数量不超过198.4万股,占公司股份总数的0.97%, 减持价格按市场价格确定。 ...